The Global Companion Diagnostics Market was valued at USD 2.03 billion in 2016 and is projected to reach USD 10.30 billion by 2025, growing at a CAGR of 19.78% from 2017 to 2025.

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product.

Sample Infographics:






Market Dynamics:
1. Market Drivers
1.1 Improvements in Regulatory Guidelines
1.2 Increase in the number of cancer patients all over the globe
1.3 Growing demands of targeted therapies
1.4 Increasing collaborations to promote companion diagnosis technology

2. Market Restraints
2.1 Reimbursement issues depending on regional economy

Market Segmentation:
1. Global Companion Diagnostics Market, by End User:
1.1 Pharma and Biotech Companies
1.2 Reference Laboratories
1.3 Others

2. Global Companion Diagnostics Market, by Indication:
2.1 Oncology
2.1.1 Breast Cancer
2.1.2 Lung Cancer
2.1.3 Colorectal Cancer
2.1.4 Melanoma
2.1.5 Gastric Cancer
2.1.6 Other Cancers Toiletries
2.2 Neurology
2.3 Infectious diseases
2.4 Other indications

3. Global Companion Diagnostics Market, by Products and Services:
3.1 Assay Kits and Reagents
3.2 Software & Services

4. Global Companion Diagnostics Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. F. Hoffmann-La Roche AG
2. Agilent Technologies, Inc.
3. Qiagen N.V.
4. Thermo Fisher Scientific Inc.
5. Abbott Laboratories, Inc.
6. Biomérieux SA
7. Danaher Corporation
8. Illumina, Inc.
9. Myriad Genetics, Inc.
10. Arup Laboratories Inc.
11. Sysmex Corporation
12. Hologic Inc.
13. Novartis AG
14. Almac Group
15. Abnova Corporation

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Companion Diagnostics Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL COMPANION DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL COMPANION DIAGNOSTICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL COMPANION DIAGNOSTICS MARKET, BY END USER
5.1 Pharma and Biotech Companies
5.2 Reference Laboratories
5.3 Others

6 GLOBAL COMPANION DIAGNOSTICS MARKET, BY INDICATION
6.1 Oncology
6.1.1 Breast Cancer
6.1.2 Lung Cancer
6.1.3 Colorectal Cancer
6.1.4 Melanoma
6.1.5 Gastric Cancer
6.1.6 Other Cancers Toiletries
6.2 Neurology
6.3 Infectious diseases
6.4 Other indications

7 GLOBAL COMPANION DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES
7.1 Assay Kits and Reagents
7.2 Software & Services

8 GLOBAL COMPANION DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

9 GLOBAL COMPANION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 F. Hoffmann-La Roche AG
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Agilent Technologies, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Qiagen N.V.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Thermo Fisher Scientific Inc.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Abbott Laboratories, Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Biomerieux SA
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Danaher Corporation
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Illumina, Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Myriad Genetics, Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Arup Laboratories Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Sysmex Corporation
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Hologic Inc.
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

10.13 Novartis AG
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments

10.14 Almac Group
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments

10.15 Abnova Corporation
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Developments

11 Appendix
11.1 Related Reports

Pet Companion Robot Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Pet Companion Robot Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/p...

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...

Europe Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...

North America Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...

Global Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...

In Vitro Diagnostics Analyzers Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The In Vitro Diagnostics Analyzers Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...

Tuberculosis Diagnostics Testing Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Tuberculosis Diagnostics Testing Market  is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...

Companion Animal Diagnostics Imaging Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Companion Animal Diagnostics Imaging Market  is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...

In Vitro Diagnostics (IVD) Tests For Autoimmune Diseases Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The In Vitro Diagnostics (IVD) Tests For Autoimmune Diseases Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, c...

Digital Diagnostics System Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Digital Diagnostics System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...